Hong Kong Stock Movement | CLOUDR (09955) Surges Over 4% in Morning Session as Company's Generative Medical AI Large Model Research Project Selected for Hangzhou Key Scientific Research Plan

Stock News
08/01

CLOUDR (09955) surged over 4% in morning trading. As of press time, the stock was up 4.03% to HK$1.55, with a turnover of HK$3.1421 million.

On the news front, Hangzhou Science and Technology Bureau recently officially announced the list of approved projects for the "2025 Municipal Key Scientific Research Plan." CLOUDR's (Hangzhou Kangsheng Health Management Consulting Co., Ltd.) project titled "Construction of Generative Medical AI Large Model and Key Technology Research for Remote Decision Support" successfully made the list, once again demonstrating the company's strong capabilities in the medical AI field.

Currently, the medical AI large model has been piloted in multiple hospitals nationwide, with plans to further expand coverage and application depth to benefit more medical institutions and patients.

According to reports, CLOUDR's generative medical AI large model is based on a medical information transmission system utilizing IoT sensing technology and precise data routing algorithms. Through multimodal sensing devices, it conducts dynamic data collection of health parameters for chronic disease patients in typical clinical scenarios, establishing encrypted transmission channels and data cleaning mechanisms for telemedicine.

The company has also developed an intelligent diagnostic assistance system with parameter self-optimization capabilities. Through deep reinforcement learning, it achieves real-time dynamic tuning of decision model parameters, focusing on improving the accuracy and timeliness of remote diagnosis for clinical scenarios including diabetes, cardiovascular diseases, and chronic obstructive pulmonary disease. This creates a comprehensive closed-loop medical assistance system covering "data collection - secure transmission - intelligent decision-making."

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10